Introduction to Human Whole Exome Sequencing
Human whole exome sequencing (WES) is a technique used to sequence all the protein-coding regions of the human genome, known as exome. The exonic region constitutes about 1-2% of the human genome but contains approximately 85% of the known disease-related variants. By targeting these regions, human whole exome sequencing (hWES) allows one to analyse various genomic variants, germline mutations and somatic mutations. It is a cost-effective alternative to human whole genome sequencing and has applications in diverse areas such as identifying genetic disease-related variants, discovering biomarkers and therapeutic targets, studying complex diseases, cancer research, or human population genetics.
Novogene has extensive experience with human whole exome sequencing with a variety of commercial WES panels from leading providers such as IDT, Twist, Agilent etc. Our hWES service is complete with high-quality data, bioinformatics analysis with variant annotation and “publication-ready’’ figures accompanying the analysis.
Applications of Human Whole Exome Sequencing
Human whole exome sequencing has applications in several fields such as:
- Detection of genomic variants for research and/or diagnostics
- Cancer research
- Clinical research
- Evolutionary biology
Benefits of Novogene’s Human Exome sequencing service
- Extensive Experience: Novogene has extensive experience with human whole exome sequencing using variety of mainstream WES panels such as from IDT, Agilent, Twist etc.
- Choice of WES panels: We support projects using WES panels from variety of commercial vendors such as IDT, Twist, Agilent etc. Our Twist WES data is complete with mtDNA panel, providing you with insights regarding mitochondrial variants.
- High-Quality Data: We deliver high-quality sequencing data that meets leading industry standards.
- Bioinformatics Support: We provide comprehensive bioinformatics support, including SNV, InDel, CNV analysis, complete with ‘publication ready’ figures using your data base of choice.
- Short Read and Long Read Sequencing: Novogene provides the option of carrying out your sequencing projects with your choice of sequencing strategy, short read and long read, using the latest sequencing platforms on the market.
- Fast Turnaround Times: Our sequencing labs are located near you, in Germany and the UK, allowing for reduced shipping times. With our large sequencing capacity, automated and streamlined workflows, we ensure that you receive your data promptly without compromising on quality
- Customer Service System (CSS): Novogene’s Customer Self Service System (CSS) is an online project management portal that streamlines project management and provides direct access to all your sequencing projects in one place. You can view your sequencing project(s), track their progress, access reports, collaborate with your team members, and obtain other useful information at one place.
Whole Exome and Target Region Sequencing Service Flyer
Whole Exome Sequencing provides a cost-effective alternative to whole genome sequencing, as it targets only the protein coding region of the human genome responsible for the majority of known disease-related variants. Whether you are conducting studies in rare mendelian disorders, complex disease, cancer research, or human population studies, Novogene’s comprehensive human whole exome sequencing service provides a high-quality, affordable, and convenient solution. Target region sequencing focuses on gene subsets related to a certain disease or phenotype and is even more cost-effective than WES when investigating regions of interest, achieving delivery of much higher coverage and identification of rare variants.
On-demand Webinar
Getting Started with Genomics: Next Generation Sequencing Essentials for 2024
This webinar will provide an accessible introduction to NGS principles and its pivotal role in decoding the secrets of DNA. It will explore the basics of DNA sequencing applications and provide insights into the array of technological platforms available, including Illumina, PacBio, and Oxford Nanopore. Whether you’re a beginner or an experienced professional, this webinar is set to offer a foundational understanding of NGS that will enhance your journey with genomic technologies.
The session will also touch upon Novogene’s contributions to the genomics field and detail the expanded services available for European customers that have contributed to this.
Learning Objectives:
- Gain foundational knowledge of NGS principles
- Understand the basics of DNA sequencing applications and technologies
- Learn about recent developments in NGS technology and services.
hWES Specifications: DNA Sample Requirements
| Service | Sample Type | Amount (Qubit®) | Volume | Concentration | Purity (NanoDrop™/Agarose Gel) |
| Human WES | Genomic DNA | ≥300 ng | ≥20 μL | ≥15 ng/μL | OD260/280 = 1.8-2.0; no degradation, no contamination Fragments longer than 3000 bp |
| FFPE* DNA | ≥300 ng | ≥20 μL | ≥15 ng/μL | Fragments longer than 1000 bp | |
| cfDNA/ctDNA* | ≥30 ng | – | ≥0.5 ng/μL | Fragments of 170 bp or its multiples, no genomic DNA contamination |
*Formalin-Fixed, Paraffin-Embedded; cell-free DNA, circulating-tumour DNA
Project Workflow of Novogene hWES Services
From sample preparation, library preparation, DNA sequencing and data quality control, to bioinformatics analysis, Novogene provides high-quality products and professional services. Each step is performed in agreement with a high scientific standard and meticulous design to ensure high-quality research results.

Publications of Human Whole Exome Sequencing
Human whole exome sequencing (hWES) enables researchers to cost-effectively unveil protein-coding variants in rare Mendelian disorders, complex disease, cancer, or human population studies. Here we summarized some outstanding academic publications that have used Novogene hWES services.
-
CLINICAL CANCER RESEARCHIssue Date: 28 June 2023IF: 11.5DOI: 10.1158/1078-0432.CCR-23-0416
-
Case report: Schnitzler-like syndrome without monoclonal gammopathy
Frontiers in ImmunologyIssue Date: 30 March 2023IF: 7.3DOI: 10.3389/fimmu.2023.1166620
-
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESIssue Date: 30 March 2023IF: 6.208DOI: 10.3390/ijms24076504
-
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESIssue Date: 1 February 2023IF: 6.208DOI: 10.3390/ijms24032790
-
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISMIssue Date: 22 January 2024IF: 5.8DOI: 10.1210/clinem/dgae034
-
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESIssue Date: 8 March 2024IF: 5.6DOI: 10.3390/ijms25063143
-
JAMA CardiologyIssue Date: April 1, 2020IF: 12.794DOI: 10.1001/jamacardio.2020.0479
-
Annals of the Rheumatic DiseasesIssue Date: 2020IF: 16.102DOI: 10.1136/annrheumdis-2019-215533
-
Journal of HepatologyIssue Date: July 23, 2019IF: 20.582DOI: 10.1016/j.jhep.2019.07.014
-
Germline BMP9 mutation causes idiopathic pulmonary arterial hypertension
European Respiratory JournalIssue Date: 2019IF: 12.339DOI: 10.1183/13993003.01609-2018
-
Cancer ResearchIssue Date: 2019IF: 9.727DOI: 10.1158/0008-5472.CAN-18-1086
-
Mutational landscape of secondary glioblastoma guides MET-targeted trial in brain tumor
CellIssue Date: October 18, 2018IF: 38.637DOI: 10.1016/j.cell.2018.09.038
-
Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma
Nature CommunicationsIssue Date: 01 March 2018IF: 12.121DOI: 10.1038/s41467-018-03276-y
Data Quality Control
Sequencing Error Rate Distribution
The sequencing error rate is the major confounding factor of precise detection of low-frequency variations by deep sequencing. It determines the quality of the sequencing data. The sequencing error rate is highly associated with the sequencing cycle, escalating towards the end of each read because of the consumption of chemical reagents, which is a common feature of the Illumina high throughput sequencing platform.

Note: The x-axis represents the position in reads, and the y-axis indicates the average error rate of bases of all reads at a position.
GC Content Distribution
GC content distribution aims to check the potential of AT/GC separation. Sample contamination, sequencing bias, and errors during library preparation can impact on the sequencing results.

Note: The x-axis represents the position in reads, and the y-axis indicates the percentage of each type of bases (A, T, G, C); different bases can be distinguished by different colors.
Alignment to Reference Genome
Sequencing Depth & Coverage Distribution
Sequencing depth and coverage illustrate the average number of pair-end clean reads which are aligned to the known reference nucleotides. The sequencing coverage distribution determines whether the identification of variations can be done with a certain degree of confidence at specific base positions.

Average sequencing depth (bar plot) and coverage (dot-line plot) in each chromosome
Note: The x-axis represents the chromosome; the left y-axis indicates the average depth; the right y-axis shows the coverage (proportion of covered bases).
SNP and InDel Calling, Annotation and Statistics
Single nucleotide polymorphisms (SNPs), also known as single nucleotide variants (SNVs), constitute the largest class of genetic variants in the genome. Another class of genetic variations includes small insertions and deletions (InDels) which are <50 bp in length. The InDels present in the coding region or splicing sites may cause changes in mRNA transcripts and proteins.

The number of SNPs/inDels in various genomic regions

The number of different types of SNPs/InDels in the coding region
Advanced Analysis
Driver Gene Analysis
Heatmap of significantly mutated genes
Only a few mutations related to cancer can drive tumorigenesis by affecting genes. Significantly mutated genes (SMGs) refer to those mutations that show a significantly higher mutation rate than the background mutation rate (BMR), thus indicating a positive selection during tumorigenesis. Analysis of SMGs helps us pinpoint the key genes that are critical for cancer initiation and progression.

Heatmap of significantly mutated genes (SMGs) across samples
Note:
The bar plot at the top shows the mutation rate of each sample (Mutations/Mb). The heatmap in the center shows the mutation types of each SMG across samples. The horizontal axis represents samples, and the vertical axis represents SMGs. Different mutation types are distinguished by different colors. The bar plot on the left side of the heatmap shows the percentage of samples affected by mutations in each SMG, and the plot on the right side shows p values of SMGs.
Tumor Heterogeneity Analysis
Intra-tumor Heterogeneity Analysis
Intra-tumor heterogeneity refers to the heterogeneous composition of tumor cells. Deciphering the intra-tumor heterogeneity and clonal architecture may contribute towards the understanding of therapeutic resistance.
The number and content (subclonal somatic mutations) of tumor subclones were identified by analyzing the variant allele frequencies of somatic mutations.

Note:
The horizontal axis of each panel represents variant allele frequency(VAF). A cluster of mutations with relatively low VAF represents a subclonal population. The top panel shows kernel density of VAFs across regions with copy number one, two, or three, posterior predictive densities summed over all clusters for copy number neutral variants, and posterior densities for each cluster/component. The panels below the top panel show read depth versus VAFs for each class of copy number regions.
*Please contact us to get the full demo report.
More Research Services




